Our Story
Lisa has 20 years of experience building early-stage companies with a focus on technology, consumer and life sciences businesses. Prior to Genome Medical, Lisa served as the chief commercial officer and chief strategy officer of Invitae (NYSE: NVTA), a rapidly growing genetic information company. She was part of the start-up team at Genome Health Inc. (Nasdaq: GHDX), president of Cinema Circle, Inc., and the former manager of strategic planning at The Walt Disney Co.
Randy is a co-founder and chairman at Genome Medical. He was formerly the chairman of Invitae, a company he co-founded and where he previously served as CEO. He also founded Genomic Health and served as Genomic Health’s chief executive officer from 2000 until 2009 and executive chairman until 2012. Under Randy’s leadership, Genomic Health developed and launched two revolutionary cancer diagnostic tests. At Incyte, Randy served in various roles from 1991 through 2000, including chairman of the board, president and chief scientific officer.
Dr. Green is co-founder and chairman of Genome Medical’s Scientific Advisory Board. He is a medical geneticist and physician-scientist who directs the G2P Research Program in translational genomics and health outcomes in the Division of Genetics at Brigham and Women’s Hospital and Harvard Medical School. Dr. Green is principal investigator of the MedSeq Project, the first NIH-funded randomized trial to explore the use of whole genome sequencing in the clinical practice of medicine.
W e are the leading genomic care delivery company — personalizing health care for all through on-demand access to genetic insights and genomic medicine. We operate as an independent virtual medical practice, powered by a digital health technology platform. By partnering with health systems, providers, health plans, employers, labs and biopharma, we expand the reach and impact of precision medicine.
Genome Medical was founded in 2016 by genetics industry leaders Lisa Alderson, MBA; Randy Scott, PhD, the executive chairman of Invitae and founder of Genomic Health; and Robert C. Green, MD, MPH, an associate member of the Broad Institute, a professor of medicine at Harvard Medical School and a medical geneticist who directs the Genomes2People Research Program at Brigham and Women’s Hospital.
”Genome Medical is a mission-driven organization bringing genomic medicine to everyday care. We are delivering the future of health care today through our nationwide network of clinical genetic experts and our efficient genomic care delivery platform. Our team is dedicated to improving patient health and reducing the cost of health care delivery.
Lisa AldersonCo-Founder and Chief Executive Officer
Investors
Genome Medical is privately funded. The company has raised more than $120 million through several rounds of financing, with its most recent Series C financing being led by Casdin Capital. In addition to Casdin, the company has a strong group of investors, including Canaan, Echo Health Ventures, Illumina Ventures, Kaiser Permanente Ventures, GV, LRV Health, Samsung, HealthInvest Equity Partners, Amgen Ventures, Perceptive Advisors, Revelation Partners and others.
